Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Serotonin-6 Receptor as a Novel Therapeutic Target
Hyung‐Mun Yun, Hyewhon Rhim
Experimental Neurobiology (2011) Vol. 20, Iss. 4, pp. 159-168
Open Access | Times Cited: 68

Showing 1-25 of 68 citing articles:

Neuronal and behavioral plasticity: the role of serotonin and BDNF systems tandem
Н. К. Попова, В. С. Науменко
Expert Opinion on Therapeutic Targets (2019) Vol. 23, Iss. 3, pp. 227-239
Closed Access | Times Cited: 84
Types of memory, dementia, Alzheimer’s disease, and their various pathological cascades as targets for potential pharmacological drugs
Ansab Akhtar, Siddharth Singh, Ravinder Kaushik, et al.
Ageing Research Reviews (2024) Vol. 96, pp. 102289-102289
Closed Access | Times Cited: 13
First-in-Class Selenium-Containing Potent Serotonin Receptor 5-HT6 Agents with a Beneficial Neuroprotective Profile against Alzheimer’s Disease
Patryk Pyka, Wawrzyniec Haberek, Małgorzata Więcek, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 2, pp. 1580-1610
Open Access | Times Cited: 12
1,3,5-Triazine-based analogues of purine: From isosteres to privileged scaffolds in medicinal chemistry
Felicia Phei Lin Lim, Anton V. Dolzhenko
European Journal of Medicinal Chemistry (2014) Vol. 85, pp. 371-390
Closed Access | Times Cited: 85
Novel multi-target-directed ligands for Alzheimer's disease: Combining cholinesterase inhibitors and 5-HT 6 receptor antagonists. Design, synthesis and biological evaluation
Anna Więckowska, Marcin Kołaczkowski, Adam Bucki, et al.
European Journal of Medicinal Chemistry (2016) Vol. 124, pp. 63-81
Closed Access | Times Cited: 81
Alzheimer’s Disease: Pathogenesis and Therapeutic Interventions
John Onyebuchi Ogbodo, Chinazom Precious Agbo, Ugochi Olivia Njoku, et al.
Current Aging Science (2021) Vol. 15, Iss. 1, pp. 2-25
Closed Access | Times Cited: 45
Serotonin Receptors as Therapeutic Targets for Autism Spectrum Disorder Treatment
Ansoo Lee, Hyunah Choo, Byungsun Jeon
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 12, pp. 6515-6515
Open Access | Times Cited: 30
Enantioselective Synthesis of Tetrahydrocarbazoles through a Michael Addition/Ciamician–Plancher Rearrangement Sequence: Asymmetric Synthesis of a Potent Constrained Analogue of MS‐245
Charles C. J. Loh, Gerhard Raabe, Dieter Enders
Chemistry - A European Journal (2012) Vol. 18, Iss. 42, pp. 13250-13254
Closed Access | Times Cited: 64
Emerging drugs to reduce abnormal β-amyloid protein in Alzheimer’s disease patients
Francesco Panza, Davide Seripa, Vincenzo Solfrizzi, et al.
Expert Opinion on Emerging Drugs (2016) Vol. 21, Iss. 4, pp. 377-391
Closed Access | Times Cited: 55
Age-Related Change in 5-HT6 Receptor Availability in Healthy Male Volunteers Measured with 11C-GSK215083 PET
Rajiv Radhakrishnan, Nabeel Nabulsi, Edward Gaiser, et al.
Journal of Nuclear Medicine (2018) Vol. 59, Iss. 9, pp. 1445-1450
Open Access | Times Cited: 55
Memory formation and memory alterations: 5-HT6 and 5-HT7 receptors, novel alternative
Alfredo Meneses
Reviews in the Neurosciences (2014) Vol. 25, Iss. 3
Closed Access | Times Cited: 47
5-HT 6 receptor blockade regulates primary cilia morphology in striatal neurons
Matthew Brodsky, Atom J. Lesiak, Alexandra Croicu, et al.
Brain Research (2017) Vol. 1660, pp. 10-19
Open Access | Times Cited: 46
Perspectives for New and More Efficient Multifunctional Ligands for Alzheimer′s Disease Therapy
Agnieszka Zagórska, Anna Jaromin
Molecules (2020) Vol. 25, Iss. 15, pp. 3337-3337
Open Access | Times Cited: 39
Multi-target-directed-ligands acting as enzyme inhibitors and receptor ligands
Diego A. Rodríguez‐Soacha, Matthias Scheiner, Michael Decker
European Journal of Medicinal Chemistry (2019) Vol. 180, pp. 690-706
Closed Access | Times Cited: 36
Zebrafish behavioural profiling identifies GABA and serotonin receptor ligands related to sedation and paradoxical excitation
Matthew N. McCarroll, Leo Gendelev, Reid Kinser, et al.
Nature Communications (2019) Vol. 10, Iss. 1
Open Access | Times Cited: 36
Antidepressant effects of p-coumaric acid isolated from Vaccinium bracteatum leaves extract on chronic restraint stress mouse model and antagonism of serotonin 6 receptor in vitro
Dool-Ri Oh, Chulyung Choi, Moon Jong Kim, et al.
Phytomedicine (2023) Vol. 116, pp. 154871-154871
Closed Access | Times Cited: 11
Study on the Comorbid Mechanisms of Sarcopenia and Late-Life Depression
Jiale Wu, Jun Tang, Di Huang, et al.
Behavioural Brain Research (2025), pp. 115538-115538
Closed Access
Unraveling the Involvement of Serotonergic 5-Hydroxytryptamine Receptor-6 Activation in Chronic Pain: A Narrative Review
Che Aishah Nazariah Ismail, Nazlahshaniza Shafin, Khairunnuur Fairuz Azman, et al.
OBM Neurobiology (2025) Vol. 09, Iss. 02, pp. 1-24
Open Access
Serotonin6 receptors in the dorsal hippocampus regulate depressive-like behaviors in unilateral 6-hydroxydopamine-lesioned Parkinson's rats
Kuncheng Liu, Junyi Li, Huihui Tan, et al.
Neuropharmacology (2015) Vol. 95, pp. 290-298
Closed Access | Times Cited: 39
Add-on clinical effects of selective antagonist of 5HT6 receptors AVN-211 (CD-008-0173) in patients with schizophrenia stabilized on antipsychotic treatment: pilot study
Morozova Ma, T. A. Lepilkina, G. Rupchev, et al.
CNS Spectrums (2013) Vol. 19, Iss. 4, pp. 316-323
Closed Access | Times Cited: 37
The potential of solanezumab and gantenerumab to prevent Alzheimer’s disease in people with inherited mutations that cause its early onset
Francesco Panza, Davide Seripa, Madia Lozupone, et al.
Expert Opinion on Biological Therapy (2017) Vol. 18, Iss. 1, pp. 25-35
Closed Access | Times Cited: 36
Thiamine and benfotiamine counteract ultrasound-induced aggression, normalize AMPA receptor expression and plasticity markers, and reduce oxidative stress in mice
Anna Gorlova, Dmitrii Pavlov, Daniel C. Anthony, et al.
Neuropharmacology (2019) Vol. 156, pp. 107543-107543
Open Access | Times Cited: 35
In vivo 5-HT6 and 5-HT2A receptor availability in antipsychotic treated schizophrenia patients vs. unmedicated healthy humans measured with [11C]GSK215083 PET
Rajiv Radhakrishnan, David Matuskey, Nabeel Nabulsi, et al.
Psychiatry Research Neuroimaging (2019) Vol. 295, pp. 111007-111007
Closed Access | Times Cited: 31
Serotonin and Depression: Scrutiny of New Targets for Future Anti- Depressant Drug Development
Arzoo Pannu, Ramesh K. Goyal
Current Drug Targets (2023) Vol. 24, Iss. 10, pp. 816-837
Closed Access | Times Cited: 10
Pharmacological approaches for Alzheimer’s disease: neurotransmitter as drug targets
Atish Prakash, Jaspreet Kalra, Vasudevan Mani, et al.
Expert Review of Neurotherapeutics (2014) Vol. 15, Iss. 1, pp. 53-71
Closed Access | Times Cited: 31
Page 1 - Next Page

Scroll to top